The article highlights the merger of Norstella and Citeline, creating a $5 billion global pharmaceutical technology company and one of the world’s largest pharma intelligence providers. The combined organization brings together data, analytics and expertise across the drug development lifecycle to help life sciences companies make better decisions and accelerate patient access to therapies.
